Riskpilot← Back to searchSign inGet full accessSB Läkarkonsulten AB
ABActiveOrg 5568846751General medical practice activities · NACE 8621Est. 20121 employees
Revenue 2025
SEK 0
EBITDA margin
—
-102% vs 2024
Equity ratio
94.2%
Financial strength
Net profit 2025
SEK 121K
+72% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -2K | -102% |
| Net profit | SEK 121K | +72% |
| Total assets | SEK 2,9M | +2% |
| Equity | SEK 2,7M | +5% |
| Employees | 1 | — |
Legal name
SB Läkarkonsulten AB
Org number
5568846751
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
17 februari 2012
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva öppenläkarmottagning inom primärvården, öppen läkarkonsult, bemanning inom hälso- och sjukvård samt konsultation och undervisning inom preventiv- och fritidsmedicin samt därmed förenlig verksamhet. Bolaget ska dessutom äga och förvalta fast och lös egendom.
Address
Phone
+46730270147
Email
edwar_toma@hotmail.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 500 | 1 939 | 430 | 17 | 0 |
| Staff expenses | — | −502 | −17 | −3 | −0 |
| EBITDA | 462 | 1 377 | 372 | 86 | −2 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 462 | 1 377 | 372 | 86 | −2 |
| Net financials | 360 | 2 | 46 | 42 | 123 |
| Profit before tax | 822 | 1 379 | 318 | 93 | 121 |
| Tax | −132 | −284 | −65 | −22 | −0 |
| Net profit | 690 | 1 095 | 252 | 70 | 121 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 510 | 2 622 | 2 780 | 2 822 | 2 875 |
| Equity | 1 351 | 2 266 | 2 518 | 2 589 | 2 709 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 159 | 356 | 162 | 99 | 30 |
| Total debt | 159 | 356 | 162 | 99 | 30 |
EBITDA margin
-205600.0%
This company
15.8%
Market median
-1301366% vs market
20212025
Equity ratio
94.2%
This company
38.2%
Market median
+147% vs market
20212025
Return on equity
4.5%
This company
18.4%
Market median
-76% vs market
20212025
Net profit margin
12072900.0%
This company
8.1%
Market median
+149048048% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
ET | Deputy Board Member | 2022 |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SB Läkarkonsulten AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Edwar Toma | Board of Directors | 0 companies |
| Eva Toma | Deputy Board Member | 0 companies |